Skip to main content

Peer Review reports

From: Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer

Original Submission
22 Feb 2019 Submitted Original manuscript
18 Mar 2019 Reviewed Reviewer Report - Hiromichi Kosaka
31 Mar 2019 Reviewed Reviewer Report - Ashok Dilly
14 Apr 2019 Author responded Author comments - Lena-Christin Conradi
Resubmission - Version 2
14 Apr 2019 Submitted Manuscript version 2
29 Apr 2019 Reviewed Reviewer Report - Hiromichi Kosaka
8 May 2019 Reviewed Reviewer Report - ning wei
17 May 2019 Reviewed Reviewer Report - Ashok Dilly
20 Jun 2019 Author responded Author comments - Lena-Christin Conradi
Resubmission - Version 3
20 Jun 2019 Submitted Manuscript version 3
21 Jul 2019 Reviewed Reviewer Report - ning wei
22 Jul 2019 Reviewed Reviewer Report - Hiromichi Kosaka
22 Jul 2019 Reviewed Reviewer Report - Ashok Dilly
15 Aug 2019 Author responded Author comments - Lena-Christin Conradi
Resubmission - Version 4
15 Aug 2019 Submitted Manuscript version 4
Publishing
18 Aug 2019 Editorially accepted
5 Sep 2019 Article published 10.1186/s12885-019-6051-0

You can find further information about peer review here.

Back to article page